Cited by 86Nerve injury and regenerationNeurogenesis and neuroplasticity mechanismsAlzheimer's disease research and treatments

Neurotrophic Property of Geniposide for Inducing the Neuronal Differentiation of PC12 Cells

Liu, Jianhui, Zheng, Xuxu, Yin, Fei, Hu, Yinhe, Guo, Lixia, Deng, Xiaohong, Chen, Gang, Jiajia, Jing +1 more·2006·International Journal of Developmental Neuroscience

Abstract

The emerging data show that the insulinotrophic hormone glucagon-like peptide-1(GLP-1) and its agonist extendin-4 have neurotrophic function to inducing neuronal differentiation of PC12 cells and prevent neurons damage challenged by oxidative stress. Here, with the model of high throughput screen for GLP-1 receptor agonists, we screen and identify that geniposide is a novel agonist for GLP-1 receptor. Furthermore, geniposide induces the neuronal differentiation of PC12 cells with resulting neurites outgrowth; we also observe an increase in expression of growth-associated protein-43. U0126, a selective MEK inhibitor, prevents neurites out growth and phosphorylation of mitogen-activated kinase proteins in PC12 cells induced by geniposide. All these results show that activation of GLP-1 receptor by geniposide to induce the neuronal differentiation of PC12 cells involves in MAPK signaling cascade.

Integrity signals

Registry

Crossref · 10.1016/j.ijdevneu.2006.08.009

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Geniposide protects PC12 and SH-SY5Y cells from oxidative damage and apoptosis by modulating MAPK signaling, caspases, and increasing SOD and GPx.

    “geniposide has been demonstrated to protect PC12 and SH-SY5Y cells from oxidative damage and apoptotic processes, by modulating the MAPK signaling pathways and caspases expression and by increasing the levels of SOD and GPx (Liu et al., 2006; Liu et al., 2007; Yin et al., 2010a; Yin et al., 2010b; Sun et al., 2013)”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Liu, J., Zheng, X., Yin, F., Hu, Y., Guo, L., Deng, X., Chen, G., Jiajia, J., & Zhang, H.
Affiliations
  • Chongqing Technology and Business University (CN)
  • East China Normal University (CN)
  • Research Center of Pharmaceutical Chemistry & Chemobiology Chongqing Technology and Business University Chongqing 400067 China
Corresponding author
  • Liu, Jianhui
  • Zheng, Xuxu
Venue
International Journal of Developmental Neuroscience
Publisher
Wiley
Published
2006-10-11
Volume
24
Issue
7
Pages
419-424
ISSN
  • 0736-5748 (ISSN-L)
  • 1873-474X
OpenAlex
W1971636741
Cited by
86
References
19
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 7 · 2014: 7 · 2013: 6 · 2012: 4
FWCI
0.76
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Developmental Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
Chongqing science and technology committee in the form of key natural science foundation (2004BA5015)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
geniposide, GLP-1 receptor agonists, glucagon-like peptide-1, neuronal differentiation, PC12 cells, neurite outgrowth, growth-associated protein 43, MAPK signaling, MEK inhibition, neurotrophic effects
MeSH terms
Glucagon-Like Peptide-1 Receptor, Animals, Butadienes, Cell Differentiation, Cell Line, Dose-Response Relationship, Drug, Drug Interactions, Enzyme Inhibitors, Colforsin, Humans, Luciferases, Neurons, Nitriles, Pyrans, Transfection, Blotting, Western, Gene Expression, PC12 Cells, Receptors, Glucagon, Neuroprotective Agents, GAP-43 Protein, Mitogen-Activated Protein Kinase Kinases, Nerve Growth Factor, Iridoids, Rats, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review